Contraceptive adherence among HIV-infected women in Malawi: A randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate

Contraception

Volumn 88, Issue 6, 2013, Pages 737-743

  Haddad, Lisa B ^a   Cwiak, Carrie ^a   Jamieson, Denise J ^a   Feldacker, Caryl ^b,c   Tweya, Hannock ^b   Hosseinipour, Mina ^d,e,f   Hoffman, Irving ^d   Bryant, Amy G ^d   Stuart, Gretchen S ^d   Noah, Isaac ^b   Mulundila, Linly ^b   Samala, Bernadette ^b   Mayne, Patrick ^g   Phiri, Sam ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LIGHTHOUSE TRUST   (Malawi)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^f MINISTRY OF HEALTH   (Malawi)

^g BROWN UNIVERSITY   (United States)

Author keywords

Adherence; Contraception; Depot medroxyprogesterone acetate; DMPA; HIV; IUD

Indexed keywords

COPPER INTRAUTERINE DEVICE; MEDROXYPROGESTERONE ACETATE;

ABDOMINAL PAIN; ADULT; AMENORRHEA; ARTICLE; BACKACHE; BREAST TENDERNESS; CONTRACEPTION; CONTRACEPTIVE BEHAVIOR; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; DYSPAREUNIA; FEMALE; HAIR LOSS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIBIDO; MAJOR CLINICAL STUDY; MALAWI; MEDICATION COMPLIANCE; MENSTRUATION; MENSTRUATION DISORDER; MUSCLE CRAMP; NAUSEA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SPOTTING; TREATMENT OUTCOME; TREATMENT REFUSAL; VAGINA DISCHARGE; WEIGHT GAIN; WEIGHT REDUCTION;

ADHERENCE; CONTRACEPTION; DEPOT MEDROXYPROGESTERONE ACETATE; DMPA; HIV; IUD;

ADULT; CONTRACEPTION BEHAVIOR; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HIV INFECTIONS; HUMANS; INTRAUTERINE DEVICES, COPPER; MALAWI; MEDROXYPROGESTERONE ACETATE; PATIENT COMPLIANCE;

EID: 84887991591     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2013.08.006     Document Type: Article

References (31)

1. UNAIDS. UNAIDS Report on the global AIDS epidemic. 2010.
2. J.M. Westfall, D.S. Main, and L. Barnard Continuation rates among injectable contraceptive users Fam Plan Perspect 28 1996 275 277
3. H. Sangi-Haghpeykar, A.N. Poindexter 3rd, L. Bateman, and J.R. Ditmore Experiences of injectable contraceptive users in an urban setting Obstet Gynecol 88 1996 227 233
4. J. Smit, and M. Beksinska Hormonal contraceptive continuation and switching in South Africa: Implications for evaluating the association of injectable hormonal contraceptive use and HIV J Acquir Immune Defic Syndr 62 3 2013 363 365
5. K. Nanda, C.S. Morrison, and C. Kwok Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda Zimbabwe and Thailand Contraception 83 2011 542 548
6. J.F. Peipert, Q. Zhao, and J.E. Allsworth Continuation and satisfaction of reversible contraception Obstet Gynecol 117 2011 1105 1113
7. Malawi Ministry of Health. Malawi Demographic and Health Survey (MDHS). 2010.
8. Macro. NSONaI. Malawi Demographic and Health Survey 2010. Zomba, Malawi and Calverton Maryland, USA: NSO and ICF Macro; 2011.
9. J.R. Chinkonde-Nkhoma, M. Hosseinipour, and I. Mofolo A review of the 'Option B Plus' roll-out in the five districts of Malawi AIDS 2012: International AIDS conference. Washington DC, USA 2012
10. B. Tippett Barr, E. Mhango, and L. Tenthani Uptake and retention in Malawi's Option B + PMTCT program: Lifelong ART for all HIV + pregnant or lactating women 20th Conference on Retroviruses and Opportunistic Infections (CROI). Atlanta, GA, USA 2013
11. M.M. Ali, R.K. Sadler, J. Cleland, T.D. Ngo, and I.H. Shah Long-term contraceptive protection, discontinuation and switching behaviour: intrauterine device (IUD) use dynamics in 14 developing countries London: World Health Organization and Marie Stopes International 2011
12. L. Haddad, M. Nyirenda, and H. Tweya Successful integration of family planning into HIV care in Lilongwe, Malawi" 2011 International AIDS Society Rome, Italy
13. World Health Organization. Medical Eligibility Criteria for contraceptive use, 4th ed. 2009.
14. Ministry of Health Malawi, National AIDS Commision and World Health Organization. Management of sexually transmitted infections using a syndromic management approach - Guidelines for service providers. V1 ed. 2007.
15. StataCorp. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP; 2009.
16. R. Hatcher, J. Trussell, A. Nelson, W. Cates, F. Stewart, and D. Kowel Contraceptive technology 20th ed. 2011 Ardent Media New York, N.Y.
17. World Health Organization Department of Reproductive Health and Research (WHO/RPR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP). Family Planning: A Global Handbook for Providers. Baltimore and Geneva: CCP and WHO; 2007.
18. E.M. Stringer, C. Kaseba, and J. Levy A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus Am J Obstet Gynecol 197 2007 144e1 144e8
19. N.L. Stanwood, J.M. Garrett, and T.R. Konrad Obstetrician-gynecologists and the intrauterine device: a survey of attitudes and practice Obstet Gynecol 99 2002 275 280
20. S.M.C. van Zijl, and Z.M. van der Spuy A survey to assess knowledge and acceptability of the intrauterine device in the family planning services in Cape Town, South Africa J Fam Plann Reprod Health Care 36 2010 73 78
21. J. Barden-O'Fallon, I. Speizer, F. Rodriguez, and J. Calix Experience with side effects among users of injectables, the IUD, and oral contraceptive pills in four urban areas of Honduras Health Care Women Int 30 2009 475 483
22. E. Tolley, S. Loza, L. Kafafi, and S. Cummings The impact of menstrual side effects on contraceptive discontinuation: findings from a longitudinal study in Cairo, Egypt Int Fam Plan Perspect 31 2005 15 23
23. M.M. Ali, and J. Cleland Contraceptive switching after method-related discontinuation: levels and differentials Stud Fam Plann 41 2010 129 133
24. M.M. Ali, and J. Cleland Oral contraceptive discontinuation and its aftermath in 19 developing countries Contraception 81 2010 22 29
25. S. Sunyavivat, T. Chumnijarakij, Y. Onthuam, A.H. Mehyar, B. Busca, and B. Christian Reasons for discontinuing contraception among women in Bangkok Bull World Health Organ 61 1983 861 865
26. R. Heffron, D. Donnell, and H. Rees Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study Lancet Infect Dis 12 1 2012 19 26
27. H. Wand, and G. Ramjee The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections AIDS 26 2012 375 380
28. S.E. Reid, J.Y. Dai, and J. Wang Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women J Acquir Immune Defic Syndr 53 2010 606 613
29. C.S. Morrison, S. Skoler-Karpoff, and C. Kwok Hormonal contraception and the risk of HIV acquisition among women in South Africa AIDS 26 2012 497 504
30. C.A. Blish, and J.M. Baeten Hormonal contraception and HIV-1 transmission Am J Reprod Immunol 65 2011 302 307
31. World Health Organization (WHO). Hormonal contraception and HIV Technical Statement, February 16, 2012. Available at http://whqlibdoc.who.int/hq/2012/ WHO-RHR-12.08-eng.pdf.